Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Hansard Adam Create: Alert

All | News | Filings
Date FiledTypeDescription
09/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2023 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Sold 4,495 shares @ $0.91, valued at $4.1k
Granted 300,000 shares @ $0
08/04/2022 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Disposed/sold 50,000 options to buy @ $2.02, valued at $101k
Disposed/sold 50,000 options to buy @ $1.05, valued at $52.5k
Disposed/sold 21,100 options to buy @ $4.17, valued at $88k
Disposed/sold 21,100 options to buy @ $1.05, valued at $22.2k
Disposed/sold 21,100 options to buy @ $9.44, valued at $199.2k
Disposed/sold 32,339 options to buy @ $23.15, valued at $748.6k
Disposed/sold 32,339 options to buy @ $1.05, valued at $34k
Disposed/sold 104,665 options to buy @ $34.28, valued at $3.6M
Disposed/sold 104,665 options to buy @ $1.05, valued at $109.9k
04/15/2022 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $2.02, valued at $101k
01/11/2022 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 31,700 shares @ $0
Granted 21,100 options to buy @ $4.17, valued at $88k
01/11/2022 4/A Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 31,700 shares @ $0
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2021 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Sold 2,894 shares @ $18.35, valued at $53.1k
12/14/2020 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 81,700 options to buy @ $23.15, valued at $1.9M
03/11/2020 4 Hansard Adam (Chief Commercial Officer) has filed a Form 4 on Applied Therapeutics Inc.
Txns: Granted 36,464 shares @ $0
Granted 179,425 options to buy @ $34.28, valued at $6.2M
03/05/2020 3 Hansard Adam (Chief Commercial Officer) has filed a Form 3 on Applied Therapeutics Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy